ValiRx plc announced that Adrian de Courcey will join the ValiRx Board as a proposed Non-Executive Director, subject to completion of regulatory due diligence and Ray Horn will become a Board observer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.875 GBX | -2.54% | -11.54% | -51.27% |
May. 20 | London gets boost thanks to rate cut hopes | AN |
May. 20 | ValiRx shares jump as Cytolytix gets Knowledge Transfer Voucher grant | AN |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-51.27% | 4.97M | |
+14.44% | 118B | |
+12.75% | 106B | |
-3.84% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-18.34% | 15.56B | |
+4.16% | 13.63B | |
+27.35% | 12.27B |
- Stock Market
- Equities
- VAL Stock
- News ValiRx plc
- Valirx plc Announces Board Appointments, Subject to Completion of Regulatory Due Diligence